Holdings
Stonepine Capital Management, LLC
As of Jun 30, 2026, Stonepine Capital Management, LLC reported 64 positions worth US$792M. Largest: Radiopharm Theranostics Limited, Verastem, Inc. and Evolus, Inc. Common Stock. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Radiopharm Theranostics Limited | 51M | US$671M | no change | Jun 30, 2026 |
| Verastem, Inc. | 3.35M | US$12.8M | +47,327 | Jun 30, 2026 |
| Evolus, Inc. Common Stock | 1.59M | US$11M | −169K | Jun 30, 2026 |
| Tenax Therapeutics, Inc. | 660K | US$9.6M | −315K | Jun 30, 2026 |
| Nektar Therapeutics | 121K | US$8.42M | +35,654 | Jun 30, 2026 |
| Adma Biologics Inc | 740K | US$6.19M | no change | Jun 30, 2026 |
| Camp4 Therapeutics Corporation | 1.39M | US$6.07M | no change | Jun 30, 2026 |
| Eloxx Pharmaceuticals, Inc. | 397K | US$5.51M | new | Jun 30, 2026 |
| Indivior Pharmaceuticals, Inc. | 100K | US$4.1M | new | Jun 30, 2026 |
| Corbus Pharmaceuticals Holdings, Inc. | 425K | US$3.99M | +41,538 | Jun 30, 2026 |